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Metallodithiolate Ligands for Reversing
Metal ion Induced Aggregation of Beta Amyloid
Background and Significance
Preliminary Chelation Studies with NiN2S2 Metallodithiolate Ligands Summary
Socioeconomic Impact of Alzheimer Disease Role of Aβ and Small Biomolecules in Neurodegeneration and Cognitive Decline  
o Sixth leading cause of death in 
the US
o No prevention or cure
o 68% increase in number of 
patients with Alzheimer's in last 
10 years
o $214 billion/year on patient 
treatment and care
o Excludes research funding
How can the Amyloid Cascade Hypothesis be used as a 
guideline for drug development?
Eleanor K. Adams and Marilyn Rampersad Mackiewicz†
†Department of Chemistry, Portland State University, Portland, Oregon
Current Clinical Trials for Alzheimer’s Disease
o Antibody and Chelation Therapy have shown promising results in 
Clinical Trials
o Research has been done showing that metal chelators can reverse
and/or inhibit Aβ aggregation
2015 Costs of Alzheimer’s= $226 Billion
Projected Alzheimer’s Disease Prevention
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Fluorescence Intensity Studies 
Amyloid Cascade Hypothesis: Aβ Involvement in Alzheimer’s Disease 
Progression
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Metal-Induced Aggregation Studies with Aβ1-42 Peptides
λex = 544 nm in 10mM PBS pH 8.0
o These different species can be formed by interacting with:
o Differences in pH and/or temperature
o Metal ions
Aβ1-42  + Cu
II
Aβ1-42  + Cu
II + NiN2S2 
Aβ1-42 incubated 24 hours
Aβ1-42 incubated 2 hours
NiN2S2 Complexes as Metal Capture Agents: Structure, Metal Addition and Binding
o NiN2S2 ligands bind to a wide array of metals to 
form a variety of molecular complexes
o Metal binding is dependent on the metal and the 
metal: ligand ratio
o UV-Vis spectroscopy is used to monitor metal 
binding by spectral changes when NiN2S2 is 
titrated with metal ions
o Changes in the d-d transitions can be seen, 
revealing the binding formation of NiN2S2 with 
Cu+
o We have demonstrated that fluorescence anisotropy is a sensitive
and rapid spectroscopic method to detect changes in protein
conformation and aggregation in the presence of metal ions and
small biomolecules on Aβ1-42
o When exposed to an aqueous environment Aβ1-42 is found to
undergo pH dependent self-aggregation into larger species over 24 h
o Aβ1-42 aggregates much faster at lower pH
o At pH 8.0 the structures are 4-97 nm tall and 1-3 nm wide
o Preliminary metal binding studies show that at:
o pH 8.0 the hydrodynamic radius is greater for CuII > ZnII > FeIII
o pH 6.6 the hydrodynamic radius is greater for FeIII > CuII > ZnII
o AFM confirms metals induce rapid aggregation to form large
oligomeric structures and is reversible upon the addition of a
chelator, EDTA
o EDTA prevents metal-induced aggregation by CuII and ZnII except in
the case of FeIII, which causes an increase in r
o Preliminary studies with metallodithiolate ligands show that:
o NiN2S2 is able to reverse aggregation in Aβ1-42 induced by Cu
II
o NiN2S2 causes conformational changes in Cu
II and FeIII witnessed by
UV-vis, color change and AFM studies
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UV-Vis spectral monitor of NiN2S2 titrated with  20 
μL additions of 0.1 M Cu
λex = 544 nm in 10mM PBS pH 8.0 λex = 544 nm in 10mM HEPES pH 6.5
Studying Metal-Induced Aggregation of Aβ1-42 by Cu
2+ , Zn2+, and Fe3+
o Flourescence studies show a decrease in fluorescence intensity suggesting metals bind to Aβ1-42
and an increase in flourescence intensity upon addition of EDTA chelator suggesting reversible 
metal binding
o Increased anisotropy of TAMRA-Aβ1-42 observed upon addition of Cu
II ions, while a decreased is 
observed upon addition of EDTA also indicating metal binding is reversible
Aβ1-42 + Cu
II Aβ1-42 + Cu
II + EDTAAβ1-42
o Preliminary studies show that: 
o Metal-induced aggregation by CuII is reversible with 
chelator metallodithiolate, NiN2S2 complexes
o Aggregation reversal depends on metals affinity for 
NiN2S2 over Aβ1-42
o CuII binding appears reversible compared to FeIII and ZnII
o AFM show larger oligomeric structures that range in size from 20-25 nm tall and 500-100
nm wide demonstrating that addition of CuII to Aβ1-42 results in its aggregation
o Incubating Aβ1-42 for 24 hours causes oligomeric structures from 30-40 nm tall and 2-4
nm wide. There is also an appearance of fibril-like structures. They are 5-6 nm long.
This results an aggregation stage past oligomers
o In addition, AFM images confirm that addition of EDTA reverses metal-induced
aggregation of Aβ1-42 as evident by smaller oligomeric structures that range in size from 2-
5 nm tall and 1-2.5 nm wide
AFM studies of NiN2S2 Interactions with 
Metal Ions and Metallodithiolate Chelators 
Fluorescence Anisotropy of Aβ1-42 Aggregation 
by CuII.,  ZnII,  and Fe
III
Studying Aggregation of Aβ1-42 with Atomic Force Microscopy
Email: mackiewi@pdx.edu Twitter: @Mack_Lab
Golden, Melissa L; et al Inorganic Chemistry, 44(4), 875-883. 
o Preliminary studies show that: 
o pH 8.0 the hydrodynamic radius is greater for CuII > ZnII > FeIII
o pH 6.6 the hydrodynamic is greater for FeIII > CuII > ZnII
o Indicates that oligomer size is dependent on metal type and pH
o Metal-induced aggregation is reversible with chelator except in the presence of 
FeIII ions
Fluorescence Anisotropy Studies
Aβ1-42  + Zn
II
Aβ1-42  + Zn
II + NiN2S2 
Aβ1-42  + Fe
III
Aβ1-42  + Fe
III + NiN2S2 
o Changes in the UV-Vis spectra show:
o Significant changes in the d-d transitions after addition NiN2S2 with Aβ1-42 indicating NiN2S2 undergoes metal capture
o No significant changes in the d-d transitions after addition NiN2S2 with Aβ1-42 and Zn
II suggesting that no complex 
formation occurs between NiN2S2 and Zn
II 
Monitoring Interaction of Aβ1-42 with Cu
2+ , Zn2+, and Fe3+ with and 
NiN2S2 with UV-Vis Spectroscopy
Height: 3 nm
Width: 10 nm










o NiN2S2 addition to metallated-Aβ species show evidence of decrease in aggregate size indicating partial 
reversibility with CuII and ZnII
o Reversibility to monomeric form not observed and is consistent with the flourescence anisotropy data
o No reversibility is observed with FeIII
